NIS to examine disease activity in SLE patients treated with subcutaneous anifrolumab in routine care

Trial Identifier: D3461R00100
Sponsor: AstraZeneca
Collaborator:
None
Start Date: March 2026
Primary Completion Date: August 2029
Study Completion Date: August 2029
Condition: Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Germany Bad Bramstedt, Germany
Germany Berlin, Germany
Germany Heidelberg, Germany
Germany Kassel, Germany
Germany Muenchen, Germany
Germany Wuppertal, Germany